Yoneda Masato, Hyun Jinhee, Jakubski Silvia, Saito Satoru, Nakajima Atsushi, Schiff Eugene R, Thomas Emmanuel
Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, FL 33136; Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136;
Department of Cell Biology, University of Miami Miller School of Medicine, Miami, FL 33136; and.
J Immunol. 2016 Jul 15;197(2):630-43. doi: 10.4049/jimmunol.1502677. Epub 2016 Jun 10.
Cell-intrinsic innate immunity provides a rapid first line of defense to thwart invading viral pathogens through the production of antiviral and inflammatory genes. However, the presence of many of these signaling pathways in the liver and their role in hepatitis B virus (HBV) pathogenesis is unknown. Recent identification of intracellular DNA-sensing pathways and involvement in numerous diverse disease processes including viral pathogenesis and carcinogenesis suggest a role for these processes in HBV infection. To characterize HBV-intrinsic innate immune responses and the role of DNA- and RNA-sensing pathways in the liver, we used in vivo and in vitro models including analysis of gene expression in liver biopsies from HBV-infected patients. In addition, mRNA and protein expression were measured in HBV-stimulated and DNA-treated hepatoma cell lines and primary human hepatocytes. In this article, we report that HBV and foreign DNA stimulation results in innate immune responses characterized by the production of inflammatory chemokines in hepatocytes. Analysis of liver biopsies from HBV-infected patients supported a correlation among hepatic expression of specific chemokines. In addition, HBV elicits a much broader range of gene expression alterations. The induction of chemokines, including CXCL10, is mediated by melanoma differentiation-associated gene 5 and NF-κB-dependent pathways after HBV stimulation. In conclusion, HBV-stimulated pathways predominantly activate an inflammatory response that would promote the development of hepatitis. Understanding the mechanism underlying these virus-host interactions may provide new strategies to trigger noncytopathic clearance of covalently closed circular DNA to ultimately cure patients with HBV infection.
细胞内在的固有免疫通过产生抗病毒和炎症基因,提供了一道快速的第一道防线,以抵御入侵的病毒病原体。然而,肝脏中许多这些信号通路的存在及其在乙型肝炎病毒(HBV)发病机制中的作用尚不清楚。最近对细胞内DNA传感通路的鉴定以及其在包括病毒发病机制和致癌作用在内的众多不同疾病过程中的参与,提示了这些过程在HBV感染中的作用。为了表征HBV内在的固有免疫反应以及DNA和RNA传感通路在肝脏中的作用,我们使用了体内和体外模型,包括对HBV感染患者肝活检组织中的基因表达进行分析。此外,还在HBV刺激和DNA处理的肝癌细胞系及原代人肝细胞中测量了mRNA和蛋白质表达。在本文中,我们报告HBV和外源DNA刺激导致肝细胞产生炎症趋化因子,从而引发固有免疫反应。对HBV感染患者肝活检组织的分析支持了特定趋化因子在肝脏表达之间的相关性。此外,HBV引发了更广泛的基因表达改变。包括CXCL10在内的趋化因子的诱导是由HBV刺激后黑色素瘤分化相关基因5和NF-κB依赖性通路介导的。总之,HBV刺激的通路主要激活炎症反应,这将促进肝炎的发展。了解这些病毒与宿主相互作用的潜在机制可能为触发共价闭合环状DNA的非细胞病变清除提供新策略,从而最终治愈HBV感染患者。